- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06290245
PEP Buddy Impact on Breathing, Exercise, and Sleep Quality in COPD Patients
Effect of PEP Buddy During Aerobic Training on Breathing, Exercise, and Sleep Quality in COPD Patients
Exercise intolerance and sleeping problems are among the most common symptoms experienced by patients with chronic obstructive pulmonary disease (COPD), which is associated with lung dynamic hyperinflation (DH). There was evidence that positive expiratory pressure (PEP), which less costly devices could offer, could reduce DH.
A positive expiratory pressure device improved COPD-related symptoms in more than 70% of patients with COPD.
PEP buddy is an adjunct to current COPD therapies, such as inhalers and pulmonary rehabilitation. It provides a tool for self-management and breathing re-training, reducing dyspnea and improving quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PEP devices have been wildly used to reduce breathing frequency and expiratory flow limitation, change breathing patterns, improve gas exchange, as well as result in less airway collapse and air-trapping in patients with COPD.
Increasing COPD disease severity promotes a negative impact on exercise tolerance and magnifies the level of disability. Physical activity programs appear to safely ameliorate these COPD consequences, conferring beneficial effects on dyspnea and health-related quality of life.
The combination of PEP during aerobic exercise helps to get the most benefits from the exercise for a longer time and little dyspnea and fatigue.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dokki
-
Giza, Dokki, Egypt, 11432
- Recruiting
- Faculty of physical therapy
-
Contact:
- Ebtesam N Nagy
- Phone Number: +201278141946
- Email: Dr.EbtesamNagy2@outlook.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• All gender COPD patients
- Age will be 55-65 years.
- Moderate to severe COPD patients
- emphysema on CT scan (HU ≥ - 900)
- Their FEV1 will be less than 80% predicted
- Class II obesity (BMI of 35 to < 40)
- Medically stable
- greater than 10 pack-year smoking history
Exclusion Criteria:
• Very severe COPD - Lung cancer
- Lung resection - Lung fibrosis
- Heart failure - Cognitive disorders that affect the device application
- Musculoskeletal or neurological disorders that interfere with an exercise program
- requiring invasive or non-invasive positive pressure ventilation
- inability to speak in complete sentences due to breathlessness
- suspected elevated intracranial pressure - hemodynamic instability
- recent facial, oral, or skull surgery
- active hemoptysis (more than two tablespoons of frank blood per day)
- pneumothorax - failure to comply with the research protocol.
- uncontrolled hypertension, or other concomitant respiratory diseases
- participate in any research or pulmonary rehabilitation program during the period of this study.
- imaging changes of lung disease such as occupancy, exudation, and interstitial changes on CT scan
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: study group
the participants will receive combined PEP Buddy plus the same exercise protocol as in the control group three times per week for eight weeks
|
It is a hands-free, oral PEP device (PEP buddy) which held by the patient's lips like a whistle and is attached to a necklace/lanyard.
Different grades of PEP-buddy generate expiratory pressures of 5-17cm H2O
Exercise training will start and finish with a 5-minute warm-up and cool-down on the cycle ergometers at (40% of PHR).
The cycling active phase will last for 30 min.
at 70% of HRmax (moderate-intensity continuous exercise).
|
Active Comparator: control group
the participants will perform an aerobic exercise in the form of cycling three times per week for eight weeks
|
Exercise training will start and finish with a 5-minute warm-up and cool-down on the cycle ergometers at (40% of PHR).
The cycling active phase will last for 30 min.
at 70% of HRmax (moderate-intensity continuous exercise).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
dyspnea
Time Frame: baseline and after 8 weeks
|
it will be evaluated by Shortness of Breath Questionnaire which is a 24-item patient-completed survey that evaluates the severity of dyspnea during common activities.
Each question is scored from 0 ("not at all") to 5 ("unable to do because of breathlessness"), with the sum of all scores representing the overall severity of the breathlessness on a scale of 0-120.
|
baseline and after 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pulmonary function
Time Frame: baseline and after 8 weeks
|
by using spirometer, forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), the ratio of forced expiratory volume in the first second and forced vital capacity (FEV1/FVC) will be measured
|
baseline and after 8 weeks
|
exercise capacity
Time Frame: baseline and after 8 weeks
|
six-minute walk test is a sub-maximal exercise test that will be used to assess aerobic capacity.
The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity
|
baseline and after 8 weeks
|
Sleep quality
Time Frame: baseline and after 8 weeks
|
Sleep Quality NRS is a single-item measure that instructs the patient to "select the number that best describes the quality of his sleep during the past 24 hours," where 0 is best possible sleep and 10 is worst possible sleep
|
baseline and after 8 weeks
|
Health-related quality of life (HRQoL)
Time Frame: baseline and after 8 weeks
|
St. George Respiratory Questionnaire is Disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease.
it includes 50 items of 3 components (Part 1 : Symptoms component (frequency & severity) with a 1, 3 or 12-month recall (best performance with 3- and 12-month recall); Part 2: Activities that cause or are limited by breathlessness; Impact components (social functioning, psychological disturbances resulting from airways disease) refer to current state as the recall).
Scores range from 0 to 100, with higher scores indicating more limitations.
|
baseline and after 8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/005045
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease, Chronic Obstructive
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on PEP Buddy
-
University Medical Center GroningenNot yet recruiting
-
Radboud University Medical CenterDutch Cancer SocietyRecruiting
-
University of California, IrvineNational Cancer Institute (NCI); American Cancer Society, Inc.Recruiting
-
Boston Medical CenterNational Cancer Institute (NCI); Northeastern UniversityCompletedPatient Satisfaction | Patient Compliance | Guideline AdherenceUnited States
-
The University of Texas at ArlingtonUniversity of South Florida; Center for Transportation, Equity, Decisions and...CompletedLack of Resources | Lack of MobilityUnited States
-
Birmingham Community Healthcare NHSBirmingham City UniversityCompleted
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Sally CHANCompleted
-
Wolfson Medical CenterUnknown
-
University GhentResearch Foundation FlandersCompletedPhysical Activity | Intellectual Disability | Health Promotion | AdolescentsBelgium